Exercise, antidepressant medications, and enhanced brain derived neurotrophic factor expression

Area of Science:

• Neuroscience
• Pharmacology
• Gerontology

Background:

• Alzheimer's disease (AD) management involves addressing behavioral problems.
• Physical activity and antidepressant treatments are individually studied for AD.
• Brain-derived neurotrophic factor (BDNF) is implicated in cognitive function and AD.

Purpose of the Study:

• To investigate the combined effect of physical activity and antidepressant treatment on BDNF mRNA expression in the rat hippocampus.
• To determine if combined interventions potentiate BDNF levels more than individual treatments.

Main Methods:

• Rats received daily intraperitoneal injections of imipramine or tranylcypromine for 20 days.
• Experimental groups had access to running wheels throughout the study period.
• BDNF mRNA levels were quantified using in situ hybridization and computer-assisted densitometry in specific hippocampal regions.

Main Results:

• Combined physical activity and antidepressant treatment significantly increased BDNF mRNA levels in the dentate gyrus, CA1, CA3, and CA4 fields.
• The potentiation of BDNF mRNA was greater than that achieved by either intervention alone.
• Additive effects were observed, highlighting a synergistic relationship between exercise and antidepressants.

Conclusions:

• Combined physical activity and antidepressant treatment show a potentiating effect on hippocampal BDNF mRNA expression.
• This study supports the investigation of physical exercise as an adjunct therapy to enhance antidepressant response in AD.
• Findings suggest a potential therapeutic strategy for managing AD-related behavioral disturbances.